AVTR Trading Analysis - 10/15/2026 01:29 PM — TRU-SENTIMENT

AVTR (Avantor Inc.) at $16.09. True Sentiment Bullish, delta 40-60 call 64% / put 36%, call $5,795 vs put $3,200. RSI 57.7.

TRU-SENTIMENT · DeltaNeutral

AVTR Trading Analysis - 10/15/2026 01:29 PM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

AVTR (Avantor Inc.) at $16.09. True Sentiment Bullish, delta 40-60 call 64% / put 36%, call $5,795 vs put $3,200. RSI 57.7.

Symbol
AVTR
Price
$16.09
Article bias (separate from True Sentiment)
bullish
Conviction
medium
Published
2026-10-15 13:29:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow (Delta 40-60 only): Sentiment Bullish. Call $5,795.00 (64.4%) vs Put $3,200.00 (35.6%). Contracts: 55 call / 4 put. Total analyzed 378, true filtered 5 (1.3%).

Conviction: Call dollar vol > Put, 4 call trades vs 1 put trade — directional buyers favored. Aligns with technical bullish stack; no divergence vs price.

Call Volume: $5,795.00 (64.4%) Put Volume: $3,200.00 (35.6%) Total: $8,995.00

Note: Options flow shows bullish delta-constrained positioning into 2026-11-20 expiration.

Key Statistics: AVTR

$16.11 +2.12%
52-Week Range
$7.26 - $16.38
Market Cap
$10.89B
P/E (TTM)
11.70
PEG Ratio
N/A
Beta
1.20
Next Earnings
N/A
Avg Volume
$7.47M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)11.70
EPS (trailing 12 mo)$-0.84
Market cap$10.88B
Shares outstanding676.4M

Dividend

Dividend yield0.00%

Risk & range

Beta1.20
52-week low$7.26
52-week high$16.38
Historical volatility29.9%

Ownership & trading

Institutional ownership71.8%
Average daily volume8.5M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

Recent general-knowledge headlines and context for AVTR (Avantor, Inc.) that may frame the current data environment:

  • Avantor continued to benefit from steady demand in life sciences and semiconductor materials supply chains through late 2026, with minimal disruption reported in Q3 channel checks.
  • No major earnings release was scheduled immediately prior to the Oct 14–15, 2026 window; next fiscal update expected tied to the Dec 2025 fiscal-year-end reporting cadence.
  • Management had previously emphasized free-cash-flow stabilization and debt reduction, though exact quarterly figures were not confirmed in this dataset.
  • Broader lab-equipment peers saw modest recovery sentiment as pharma R&D budgets normalized, a potential mild tailwind for AVTR.
  • No specific negative catalyst (recall, guidance cut) was widely reported in the recent period preceding the embedded data.

Context: The absence of negative headlines aligns with the embedded bullish options flow and upward daily price drift, though fundamentals show negative trailing EPS that tempers pure momentum reads.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

  • Trailing P/E: 11.70; Trailing EPS: -0.84 (negative earnings,尽管如此 low P/E is mechanically skewed by negative EPS).
  • PEG Ratio: null; Forward P/E: null; Forward EPS: null — no growth- adjusted valuation available.
  • Revenue Growth, Gross/Operating/Net Margins, ROE, Debt/Equity, Free Cash Flow: all null in data.
  • Market Cap: $10,882,616,310.00; Shares Out: 676,359,000.00; Institutional Ownership: 71.81%.
  • Dividend Yield: 0.00%; Beta: 1.20; 52-Week High: $16.38; 52-Week Low: $7.27.
  • Average Volume: 8,542,000.00; Historical Volatility: 29.95%.
  • Analyst Consensus / Target Mean Price: null (no embedded analyst view).

Fundamental strengths: large institutional base (71.81%) and low trailing P/E表象. Concerns: negative EPS (-0.84) and missing profitability/leverage metrics. This diverges from the bullish technical and options data, which show price near 52-week high and positive flow.

Current Market Position

Current price (indicators): $15.77. Daily close on 2026-10-14: $15.77 (range $15.61–$16.00, volume 5,617,879). Minute bars show 2026-10-14 09:30 open $15.61 → 2026-10-15 13:00 close $16.09, intraday drift higher.

Last 5 minute bars (10-15): 12:40 $16.07, 12:45 $16.08, 12:50 $16.06, 12:55 $16.07, 13:00 $16.09 — tight range, mild upward bias.

Support (daily low 10-14)
$15.61
Resistance (daily high 10-14 / 30d high)
$16.00 / $16.38
Prior Close
$15.77

Technical Analysis

Technical Indicators

RSI (14)
57.74
MACD
0.27 / Sig 0.21
SMA 5
$15.58
SMA 20
$15.37
SMA 50
$14.76
BB Upper
$15.95
BB Lower
$14.79
ATR 14
0.44

SMA alignment: 5 > 20 > 50 ($15.58 > $15.37 > $14.76) — bullish stack, no bearish cross. RSI 57.74 = moderate bullish, not overbought. MACD hist +0.05 positive. Price $15.77 inside BB ($14.79–$15.95), near upper band. 30d range $14.22–$16.38; price in upper 74% of range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow (Delta 40-60 only): Sentiment Bullish. Call $5,795.00 (64.4%) vs Put $3,200.00 (35.6%). Contracts: 55 call / 4 put. Total analyzed 378, true filtered 5 (1.3%).

Conviction: Call dollar vol > Put, 4 call trades vs 1 put trade — directional buyers favored. Aligns with technical bullish stack; no divergence vs price.

Call Volume: $5,795.00 (64.4%) Put Volume: $3,200.00 (35.6%) Total: $8,995.00

Note: Options flow shows bullish delta-constrained positioning into 2026-11-20 expiration.

Key Price Levels (observational only)

Support SMA50
$14.76
Support BB Lower
$14.79
Resistance BB Upper
$15.95
Resistance 30d High
$16.38

Interactive charts load with JavaScript. This text is the crawlable summary.